EP1597318A4 - Preparations sous forme d'emulsions a base de poloxameres - Google Patents

Preparations sous forme d'emulsions a base de poloxameres

Info

Publication number
EP1597318A4
EP1597318A4 EP04712958A EP04712958A EP1597318A4 EP 1597318 A4 EP1597318 A4 EP 1597318A4 EP 04712958 A EP04712958 A EP 04712958A EP 04712958 A EP04712958 A EP 04712958A EP 1597318 A4 EP1597318 A4 EP 1597318A4
Authority
EP
European Patent Office
Prior art keywords
poloxamer
emulsion preparations
preparations
emulsion
poloxamer emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04712958A
Other languages
German (de)
English (en)
Other versions
EP1597318A1 (fr
Inventor
Steen Boye Jorsal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novasel Australia Pty Ltd
Original Assignee
Novasel Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novasel Australia Pty Ltd filed Critical Novasel Australia Pty Ltd
Publication of EP1597318A1 publication Critical patent/EP1597318A1/fr
Publication of EP1597318A4 publication Critical patent/EP1597318A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP04712958A 2003-02-27 2004-02-20 Preparations sous forme d'emulsions a base de poloxameres Withdrawn EP1597318A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003900887 2003-02-27
AU2003900887A AU2003900887A0 (en) 2003-02-27 2003-02-27 Poloxamer emulsion preparations
PCT/AU2004/000218 WO2004076561A1 (fr) 2003-02-27 2004-02-20 Preparations sous forme d'emulsions a base de poloxameres

Publications (2)

Publication Number Publication Date
EP1597318A1 EP1597318A1 (fr) 2005-11-23
EP1597318A4 true EP1597318A4 (fr) 2006-06-14

Family

ID=31499933

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04712958A Withdrawn EP1597318A4 (fr) 2003-02-27 2004-02-20 Preparations sous forme d'emulsions a base de poloxameres

Country Status (9)

Country Link
EP (1) EP1597318A4 (fr)
JP (1) JP2006519272A (fr)
CN (1) CN100591721C (fr)
AU (3) AU2003900887A0 (fr)
BR (1) BRPI0408056A (fr)
CA (1) CA2516863C (fr)
EA (1) EA017434B1 (fr)
NO (1) NO20054395L (fr)
WO (1) WO2004076561A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132087B2 (en) * 2008-04-21 2015-09-15 Otonomy, Inc. Auris formulations for treating otic diseases and conditions
WO2010076730A1 (fr) * 2009-01-02 2010-07-08 Donald, Jenny Méthode de traitement d'une infection par le vih
KR101792200B1 (ko) * 2010-04-01 2017-10-31 파마네스트 아베 열감응성 겔 마취제 조성물
LT2689774T (lt) * 2011-03-21 2019-03-25 Broda Technologies Co., Ltd Atvirkščiai termiškai grįžtama hidrogelio kompozicija
ITMI20131927A1 (it) 2013-11-20 2015-05-21 Cosmo Technologies Ltd Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection. emulsioni o microemulsioni per uso nella resezione mucosale endoscopica e/o dissezione submucosale endoscopica
MX2016012288A (es) * 2014-03-25 2017-01-23 Genentech Inc Metodos para preparar un poloxamero para usar en medio de cultivo celular.
US10351750B2 (en) * 2017-02-03 2019-07-16 Saudi Arabian Oil Company Drilling fluid compositions with enhanced rheology and methods of using same
KR101852718B1 (ko) * 2017-04-04 2018-05-18 주식회사 제네웰 외과수술 후 절개부위 통증 감소를 위한 키트
SG11202002351SA (en) * 2017-12-21 2020-07-29 Sigma Aldrich Co Llc Poloxamer compositions and methods of making and using same
IT201900018752A1 (it) * 2019-10-14 2021-04-14 Alessandro Tosetti Composizione a base di olii essenziali ad uso odontoiatrico per il trattamento della periodontite e della mucosite perimplantare
RU2762506C1 (ru) * 2021-01-20 2021-12-21 Общество С Ограниченной Ответственностью «Диамед-Фарма» Средство для аппликации полости рта и носа и способ его применения в составе комплексной терапии инфекционно-воспалительных заболеваний носовой и ротовой полости
CN114455621B (zh) * 2022-01-11 2023-10-27 兰州交通大学 一种针状碳酸钙的制备方法

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003429A1 (fr) * 1988-09-23 1990-04-05 Cetus Corporation Micro-emulsions de lipides pour milieux de culture
US5698219A (en) * 1994-08-08 1997-12-16 Laboratorios Cusi, S.A. Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof
DE19723308A1 (de) * 1997-06-04 1998-12-10 Wolfgang A Prof Dr Wohlrab Neue Mikroemulsionen zur topischen Anwendung von Arzneimittelwirkstoffen
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
EP1018363A1 (fr) * 1999-01-05 2000-07-12 L'oreal Nanoémulsion à base de copolymères blocs d'oxyde d'éthylène et d'oxde de propylène, et ses utilisations dans les domaines cosmétique, dermatologique et/ou phtalmologique
WO2000051550A1 (fr) * 1999-03-01 2000-09-08 Basf Corporation Emulsions eau dans huile traitees a froid
WO2000078301A1 (fr) * 1999-06-21 2000-12-28 Kuhnil Pharm. Co., Ltd. Composition d'anesthesiant en injection intraveineuse comprenant du propofol
WO2001066087A1 (fr) * 2000-03-08 2001-09-13 Astrazeneca Ab Nouveau systeme de delivrance d'un medicament auto-emulsifiant
WO2002009671A2 (fr) * 2000-08-01 2002-02-07 University Of Florida Nouveaux systemes de micro-emulsions et de tensioactifs destines a la solubilisation de medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0791555B2 (ja) * 1989-12-22 1995-10-04 株式会社資生堂 洗浄剤組成物
SE9601421D0 (sv) * 1996-04-12 1996-04-12 Astra Ab New composition

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003429A1 (fr) * 1988-09-23 1990-04-05 Cetus Corporation Micro-emulsions de lipides pour milieux de culture
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
US5698219A (en) * 1994-08-08 1997-12-16 Laboratorios Cusi, S.A. Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof
DE19723308A1 (de) * 1997-06-04 1998-12-10 Wolfgang A Prof Dr Wohlrab Neue Mikroemulsionen zur topischen Anwendung von Arzneimittelwirkstoffen
EP1018363A1 (fr) * 1999-01-05 2000-07-12 L'oreal Nanoémulsion à base de copolymères blocs d'oxyde d'éthylène et d'oxde de propylène, et ses utilisations dans les domaines cosmétique, dermatologique et/ou phtalmologique
WO2000051550A1 (fr) * 1999-03-01 2000-09-08 Basf Corporation Emulsions eau dans huile traitees a froid
WO2000078301A1 (fr) * 1999-06-21 2000-12-28 Kuhnil Pharm. Co., Ltd. Composition d'anesthesiant en injection intraveineuse comprenant du propofol
WO2001066087A1 (fr) * 2000-03-08 2001-09-13 Astrazeneca Ab Nouveau systeme de delivrance d'un medicament auto-emulsifiant
WO2002009671A2 (fr) * 2000-08-01 2002-02-07 University Of Florida Nouveaux systemes de micro-emulsions et de tensioactifs destines a la solubilisation de medicaments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2004076561A1 *

Also Published As

Publication number Publication date
AU2004215921A1 (en) 2004-09-10
AU2009202265B2 (en) 2012-02-16
EA200501368A1 (ru) 2006-02-24
BRPI0408056A (pt) 2006-02-14
AU2009202265A1 (en) 2009-07-02
CA2516863C (fr) 2011-12-06
EA017434B1 (ru) 2012-12-28
CN1753949A (zh) 2006-03-29
WO2004076561A1 (fr) 2004-09-10
CN100591721C (zh) 2010-02-24
CA2516863A1 (fr) 2004-09-10
EP1597318A1 (fr) 2005-11-23
NO20054395L (no) 2005-09-22
AU2003900887A0 (en) 2003-03-13
JP2006519272A (ja) 2006-08-24

Similar Documents

Publication Publication Date Title
IL173808A0 (en) Pharmaceutical liposomal formulations
HK1084338A1 (en) Pharmaceutical formulation comprising lanthanum compounds
PL1687028T3 (pl) Preparaty immunoglobulin o zwiększonej stabilności
IL172824A0 (en) Pharmaceutical formulations
PL2279729T3 (pl) Preparaty o kontrolowanym uwalnianiu
GB0302671D0 (en) Pharmaceutical formulations
DE502004002225D1 (de) Selbstemulgierende Zubereitungen
EP1597318A4 (fr) Preparations sous forme d'emulsions a base de poloxameres
GB0316206D0 (en) Pharmaceutical formulation
GB0318448D0 (en) Formulation
GB0302672D0 (en) Pharmaceutical formulations
EP1369101A4 (fr) Preparation cosmetique en emulsion eau-huile-eau
EP1698671A4 (fr) Composition d'emulsion
GB0312195D0 (en) Formulation
GB0316341D0 (en) Pharmaceutical formulations
GB0320522D0 (en) Formulation
GB0316889D0 (en) Pharmaceutical agents
GB0308691D0 (en) Vaccine preparations
GB0303876D0 (en) Formulation
EP1642586A4 (fr) Preparations contenant des cellules
GB0316335D0 (en) Pharmaceutical formulations
GB0310881D0 (en) Pharmaceutical formulation
GB0327722D0 (en) Pharmaceutical formulations
GB0326642D0 (en) Pharmaceutical formulations
GB0324912D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050826

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

A4 Supplementary search report drawn up and despatched

Effective date: 20060428

17Q First examination report despatched

Effective date: 20060816

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1089197

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1089197

Country of ref document: HK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/34 20170101ALI20170421BHEP

Ipc: B01F 17/42 20060101ALI20170421BHEP

Ipc: C08L 71/02 20060101AFI20170421BHEP

Ipc: A61K 9/107 20060101ALI20170421BHEP

Ipc: C08J 3/075 20060101ALI20170421BHEP

INTG Intention to grant announced

Effective date: 20170519

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170930

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/34 20170101ALI20170421BHEP

Ipc: C08J 3/075 20060101ALI20170421BHEP

Ipc: A61K 9/107 20060101ALI20170421BHEP

Ipc: B01F 17/42 20060101ALI20170421BHEP

Ipc: C08L 71/02 20060101AFI20170421BHEP